| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Comparative Medicine
2 Department of Medicine
and3 Department of Neurology, The Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205, U.S.A.
Borna disease virus (BDV) is an unclassified agent that causes neurological disease in a wide range of animal species and possibly in humans. The infectious nature of BDV has been long established but, despite extensive progress on the pathogenesis of the infection, the aetiological agent is still uncharacterized. Recent studies have shown that BDV replicates productively in cultures of foetal rabbit glial cells (FRG) which produce a virus-specific protein that is easily detected immunocytochemically. This provides a marker for BDV infectivity. This cell culture system was used to investigate the replication cycle of BDV. The agent required at least 1 h to bind to and penetrate the cells and the antigen was detected 24 h later. Cycloheximide and actinomycin D inhibited production of the antigen in inoculated cells, indicating that both protein synthesis and a DNA-dependent function were required for the production of viral antigen. Cocultivation of BDV-infected FRG cells with Vero cells resulted in a persistent productive infection in the latter. Use of these cells showed that the infectious agent matured exclusively in the cytoplasm and within the plasma membrane of the cell. Antigen-laden nuclei did not have infectivity. These studies showed that BDV has the physical and replicative properties typical of conventional viruses but its mechanism of replication and site of morphogenesis may be unique.
Keywords: Borna disease virus, BDV replication, neurotropic agent
Received 1 February 1989;
accepted 29 July 1989.
This article has been cited by other articles:
|
|
 |
|
  R. Clemente and J. C. de la Torre Cell-to-Cell Spread of Borna Disease Virus Proceeds in the Absence of the Virus Primary Receptor and Furin-Mediated Processing of the Virus Surface Glycoprotein J. Virol., June 1, 2007; 81(11): 5968 - 5977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kobayashi, G. Zhang, B.-J. Lee, S. Baba, M. Yamashita, W. Kamitani, H. Yanai, K. Tomonaga, and K. Ikuta Modulation of Borna Disease Virus Phosphoprotein Nuclear Localization by the Viral Protein X Encoded in the Overlapping Open Reading Frame J. Virol., July 15, 2003; 77(14): 8099 - 8107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Planz, S. Pleschka, and S. Ludwig MEK-Specific Inhibitor U0126 Blocks Spread of Borna Disease Virus in Cultured Cells J. Virol., May 15, 2001; 75(10): 4871 - 4877. [Abstract] [Full Text]
|
|
|
|
|
|
D. Gonzalez-Dunia, B. Cubitt, and J. C. de la Torre Mechanism of Borna Disease Virus Entry into Cells J. Virol., January 1, 1998; 72(1): 783 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Planz, T. Dumrese, S. Hulpusch, M. Schirle, S. Stevanovic, and L. Stitz A Naturally Processed Rat Major Histocompatibility Complex Class I-associated Viral Peptide as Target Structure of Borna Disease Virus-specific CD8+ T Cells J. Biol. Chem., April 20, 2001; 276(17): 13689 - 13694. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
